NDSN
Get informed when a big investor buys or sells
+ FollowOvervalued by 11% based on the discounted cash flow analysis.
| Market cap | $16.01 Billion |
|---|---|
| Enterprise Value | $17.93 Billion |
| Dividend Yield | $3.24 (1.13%) |
| Earnings per Share | $8.56 |
| Beta | 0.99 |
| Outstanding Shares | 55,793,000 |
| P/E Ratio | 30.36 |
|---|---|
| PEG | 694.63 |
| Price to Sales | 5.57 |
| Price to Book Ratio | 5.08 |
| Enterprise Value to Revenue | 6.18 |
| Enterprise Value to EBIT | 24.27 |
| Enterprise Value to Net Income | 33 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.63 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.8550▲ 76.18% |
|---|---|
| Total Calls | 66,100▼ 13.25% |
| Total Puts | 56,514▲ 695.97% |
Holdings and activity of institutional investors.
| Ownership % | 73.86%▼ 1.55% |
|---|---|
| Total Invested | $10.96B▲ 7.75% |
| Investors Holding | 711▲ 18.00% |
No data
Nordson Corporation is an American multinational corporation that designs and manufactures dispensing equipment for consumer and industrial adhesives, sealants and coatings. The company also manufactures equipment used in the testing and...
Provides critical analysis and scoring for tax legislation, directly influencing corporate tax structures and capital investment credits which are vital for Nordson's financial performance.
Direct influence on corporate tax policy, trade regulations (affecting international operations), and entitlement spending impacting healthcare demand, all of which significantly affect Nordson.
Direct regulatory oversight of medical devices (FDA) and significant influence on labor laws both directly impact Nordson's medical device segment and manufacturing operations.